123 related articles for article (PubMed ID: 10439315)
21. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.
Nie Y; Yang G; Song Y; Zhao X; So C; Liao J; Wang LD; Yang CS
Carcinogenesis; 2001 Oct; 22(10):1615-23. PubMed ID: 11577000
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor expression correlates with p53 mutation and angiogenesis in squamous cell carcinoma of the head and neck.
Riedel F; Götte K; Schwalb J; Schäfer C; Hörmann K
Acta Otolaryngol; 2000 Jan; 120(1):105-11. PubMed ID: 10779196
[TBL] [Abstract][Full Text] [Related]
23. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
Singal DP; Ye M; Ni J; Snider DP
Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
[TBL] [Abstract][Full Text] [Related]
24. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression.
Corrias MV; Occhino M; Croce M; De Ambrosis A; Pistillo MP; Bocca P; Pistoia V; Ferrini S
Tissue Antigens; 2001 Feb; 57(2):110-7. PubMed ID: 11260505
[TBL] [Abstract][Full Text] [Related]
25. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours.
Cromme FV; van Bommel PF; Walboomers JM; Gallee MP; Stern PL; Kenemans P; Helmerhorst TJ; Stukart MJ; Meijer CJ
Br J Cancer; 1994 Jun; 69(6):1176-81. PubMed ID: 8198988
[TBL] [Abstract][Full Text] [Related]
26. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
[TBL] [Abstract][Full Text] [Related]
27. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
Lewis JW; Neisig A; Neefjes J; Elliott T
Curr Biol; 1996 Jul; 6(7):873-83. PubMed ID: 8805302
[TBL] [Abstract][Full Text] [Related]
28. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
29. HLA and MICA associations with head and neck squamous cell carcinoma.
Reinders J; Rozemuller EH; Otten HG; van der Veken LT; Slootweg PJ; Tilanus MG
Oral Oncol; 2007 Mar; 43(3):232-40. PubMed ID: 16857416
[TBL] [Abstract][Full Text] [Related]
30. Distinct differences in association of MHC class I with endoplasmic reticulum proteins in wild-type, and beta 2-microglobulin- and TAP-deficient cell lines.
Paulsson KM; Wang P; Anderson PO; Chen S; Pettersson RF; Li S
Int Immunol; 2001 Aug; 13(8):1063-73. PubMed ID: 11470776
[TBL] [Abstract][Full Text] [Related]
31. Dependence of peptide binding by MHC class I molecules on their interaction with TAP.
Grandea AG; Androlewicz MJ; Athwal RS; Geraghty DE; Spies T
Science; 1995 Oct; 270(5233):105-8. PubMed ID: 7569935
[TBL] [Abstract][Full Text] [Related]
32. Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.
Wintzer HO; Benzing M; von Kleist S
Br J Cancer; 1990 Aug; 62(2):289-95. PubMed ID: 2201398
[TBL] [Abstract][Full Text] [Related]
33. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.
Qifeng S; Bo C; Xingtao J; Chuanliang P; Xiaogang Z
J Thorac Cardiovasc Surg; 2011 Mar; 141(3):808-14. PubMed ID: 21335133
[TBL] [Abstract][Full Text] [Related]
34. Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastases.
Koene G; Mulder A; van der Ven K; Eijsink C; Franke M; Slootweg P; Claas F; Tilanus M
Hum Immunol; 2006 Sep; 67(9):692-9. PubMed ID: 17002899
[TBL] [Abstract][Full Text] [Related]
35. Molecular comparisons of the beta 2-microglobulin-binding site in class I major-histocompatibility-complex alpha-chains and proteins of related sequences.
Tysoe-Calnon VA; Grundy JE; Perkins SJ
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):359-69. PubMed ID: 1859364
[TBL] [Abstract][Full Text] [Related]
36. An unstable beta 2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide.
Sugita M; Brenner MB
J Exp Med; 1994 Dec; 180(6):2163-71. PubMed ID: 7964491
[TBL] [Abstract][Full Text] [Related]
37. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
[TBL] [Abstract][Full Text] [Related]
38. Beta 2-microglobulin gene is mutated in a human colon cancer cell line (HCT) deficient in the expression of HLA class I antigens on the cell surface.
Gattoni-Celli S; Kirsch K; Timpane R; Isselbacher KJ
Cancer Res; 1992 Mar; 52(5):1201-4. PubMed ID: 1737380
[TBL] [Abstract][Full Text] [Related]
39. Analysis of HLA class Ia transcripts in human leukaemias.
Majumder D; Bandyopadhyay D; Chandra S; Mukhopadhayay A; Mukherjee N; Bandyopadhyay SK; Banerjee S
Immunogenetics; 2005 Sep; 57(8):579-89. PubMed ID: 16133450
[TBL] [Abstract][Full Text] [Related]
40. Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma.
Kurokohchi K; Carrington M; Mann DL; Simonis TB; Alexander-Miller MA; Feinstone SM; Akatsuka T; Berzofsky JA
Hepatology; 1996 May; 23(5):1181-8. PubMed ID: 8621152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
